Company news

HemoGenyx Pharmaceuticals PLC news in 2026

HemoGenyx Pharmaceuticals PLC's news releases, calls and decks from 2026, newest first.

Feasibility Study Agreement

October 19, 2026

Total Voting Rights

September 30, 2026

Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report

September 28, 2026

Hemogenyx Pharmaceuticals PLC Announces Collaboration with Cellin Technologies

August 11, 2026

Hemogenyx Pharmaceuticals PLC Announces Collaboration and Company Update

July 29, 2026

Hemogenyx Pharmaceuticals PLC Announces Notice of AGM

June 5, 2026

Hemogenyx Pharmaceuticals PLC Announces Grant of Options and Extension of Warrant Term

May 29, 2026

Institutional Fundraise

April 28, 2026

Annual IND Report with FDA

April 14, 2026

Tech Transfer Completion and Clinical Trial Update

March 31, 2026

Total Voting Rights

February 27, 2026

Holding(s) in Company

February 24, 2026

Exercise of Warrants and Issue of Equity

February 23, 2026

CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

February 10, 2026

Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

February 10, 2026

Decks in 2026

Investor Presentation (May 2026)
Investor deck · 24 slides · May 2026